Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.
Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases.
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence.
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Inscripta is a life science technology company that develops digital genome engineering solutions.
Mindstrong is a virtual mental health platform.
Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.
Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.
Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.
Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.
Tasso is a Medical innovation company changing the way diagnostics are delivered
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Tesseract Health provides devices for disease monitoring and prevention.
Theseus Pharmaceuticals is a technology-based company.
Foresite Capital has invested in 130 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 22 different industry categories.
Among tracked funding rounds, Xaira Therapeutics received $1.0B in a Series A round. Foresite Capital's total known invested capital is $12.6B.
Foresite Capital's average investment size is $127.7M across its portfolio of 130 companies.
Recent Foresite Capital portfolio additions include Replimune Group, Alector, Relay Therapeutics, Foresight Diagnostics, Spear Bio. These companies were founded in 2020 or later.